MTCH
50
8
HBI
55
-4
DE
68
5
WBA
54
6
WDC
50
3
PCAR
58
2
MCHP
54
13
IVZ
55
6
AKAM
53
2
REGN
42
3
GRMN
70
5
BBY
41
-5
SYF
88
3
NWS
64
2
SWKS
55
5
HAL
62
2
PWR
74
2
KO
49
5
BWA
52
4
XRX
46
2
MTCH
50
8
HBI
55
-4
DE
68
5
WBA
54
6
WDC
50
3
PCAR
58
2
MCHP
54
13
IVZ
55
6
AKAM
53
2
REGN
42
3
GRMN
70
5
BBY
41
-5
SYF
88
3
NWS
64
2
SWKS
55
5
HAL
62
2
PWR
74
2
KO
49
5
BWA
52
4
XRX
46
2
Financhill
Back

Editas Medicine Vs. Adverum Biotechnologies Industry Stock Comparison

Sell
41

EDIT
Editas Medicine

Last Price:
2.21
Seasonality Move:
13.73%
Sell
38

ADVM
Adverum Biotechnologies

Last Price:
6.16
Seasonality Move:
22.26%
Sell
41
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.38. The Score for EDIT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.15. The Score for ADVM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 31.96 Sell
Chaikin Money Flow: -3498554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.6 - 3.24) Sell
Bollinger Bands (100): (2.94 - 4.74) Sell

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 33.55 Sell
Chaikin Money Flow: -115978 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.64 - 8.1) Sell
Bollinger Bands (100): (6.7 - 8) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.5 Sell
20-day SMA: 2.84 Sell
50-day SMA: 3.18 Sell
200-day SMA: 5.19 Sell
8-day EMA: 2.53 Sell
20-day EMA: 2.78 Sell
50-day EMA: 3.17 Sell
200-day EMA: 4.95 Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.42 Sell
20-day SMA: 7.2 Sell
50-day SMA: 7.38 Sell
200-day SMA: 9.77 Sell
8-day EMA: 6.43 Sell
20-day EMA: 6.97 Sell
50-day EMA: 7.28 Sell
200-day EMA: 8.75 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and an increase next year of $0.38 per share.

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):